Publications
- Hyrimoz - new biosimilars in treatment of rheumatoid arthritis2019 | Second Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
- The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective2023 | Second Faculty of Medicine
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | Second Faculty of Medicine
- Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study2022 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Immunoglobulin replacement therapy in the Czech Republic: end-of-year 2020 data from the National registry of primary immunodeficiencies2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Loading network view...